The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of brexucabtagene autoleucel (brexu-cel) for relapsed or refractory (R/R) mantle cell lymphoma (MCL): A CIBMTR subgroup analysis by prior treatment.
 
Swetha Kambhampati
No Relationships to Disclose
 
Nausheen Ahmed
No Relationships to Disclose
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Caribou Biosciences; crispr therapeutics; Gamida Cell; Genentech; Genmab; Incyte; Kite/Gilead; MorphoSys; Myeloid Therapeutics; Novartis; Omeros; Puma Biotechnology (I); Sanofi; Seagen; Verastem
Speakers' Bureau - ADC Therapeutics; AstraZeneca; BeiGene; Genzyme; Kite/Gilead
Research Funding - Astellas Pharma; Genzyme; Genzyme; Otsuka; Spectrum Pharmaceuticals; Takeda
 
Natalie Sophia Grover
Stock and Other Ownership Interests - Sangamo Therapeutics
Honoraria - ADC Therapeutics; Kite, a Gilead company; Novartis
Research Funding - Genentech
(OPTIONAL) Uncompensated Relationships - Tessa Therapeutics
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; Adaptimmune; Adaptive Biotechnologies; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Cellectar; Epizyme; Fate therapeutics; Genentech; Innate Pharma; Kite, a Gilead company; Lilly; MEI Pharma; MorphoSys; MustangBio; Pharmacyclics; Regeneron; Sound Biologics; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Frederick L. Locke
Consulting or Advisory Role - A2 Biotherapeutics; Alimera Sciences; Amgen; Bluebird Bio; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Calibr; Caribou Biosciences; Celgene; Cowen; Daiichi Sankyo/UCB Japan; EcoR1 Capital; Gerson Lehrman Group; Iovance Biotherapeutics; Janssen; Kite, a Gilead company; Legend Biotech; Miltenyi Biotec; Novartis; Sana Biotechnology; Takeda; Takeda; Umoja Biopharma; Umoja Biopharma
Research Funding - Alimera Sciences (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Kite, a Gilead company
 
James M. Gerson
Consulting or Advisory Role - Abbvie; Genentech
Research Funding - Loxo
 
Matthew Joshua Frank
Employment - Roche/Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
Honoraria - Adaptive Biotechnologies; Kite/Gilead
Consulting or Advisory Role - CARGO Therapeutics; Kite, a Gilead company
Research Funding - Adaptive Biotechnologies; Allogene Therapeutics; Kite, a Gilead company (Inst)
 
Lihua Elizabeth Budde
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; BeiGene; Kite/Gilead; Loxo/Lilly; Novartis; nurix; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Merck; MustangBio
Patents, Royalties, Other Intellectual Property - CCR4 CAR T cells for treatment of patients with CCR4 positive cancer.; CD33CAR for treatment of patients with CD33+ acute myeloid leukemia.
Travel, Accommodations, Expenses - Kite/Gilead; Roche/Genentech
 
Michael Wang
Honoraria - Abbvie; Acerta Pharma; AstraZeneca; Bantam Pharmaceutical; BeiGene; Bioinvent; Breast-Gynecological International Cancer Society; Bristol Myers Squibb Foundation; CAHON; Dava Oncology; Eastern Virginia Medical School; Genmab; IDEOlogy Health; Janssen Research & Development; Kite, a Gilead company; Leukemia and Lymphoma Society; MD Education; Medscape; Meeting Minds Experts; Merck; Moffit Cancer Center; Nurix; OncLive/MJH Life Sciences; Oncology Specialty Group; Pharmacyclics/Janssen; Physicans' Education Resource; Practice Point Communications; Studio ER Congressi
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; Amphista Therapeutics; AstraZeneca; Be Biopharma; BeiGene; Bioinvent; Deciphera; DTRM; Genentech; Innocare; Janssen Research & Development; Kite, a Gilead company; Leukemia and Lymphoma Society; Lilly; Merck; Milken Institute; Miltenyi Biomedicine; Oncternal Therapeutics; Parexel; Pepromene; Pepromene; Pharmacyclics/Janssen; VelosBio
Research Funding - Acerta Pharma; AstraZeneca; BeiGene; Bioinvent; Celgene; Genentech; Genmab; Innocare; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Lilly; Loxo; Molecular Templates; Oncternal Therapeutics; Pharmacyclics; VelosBio; Vincerx Pharma
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Kite, a Gilead company; Physicans' Education Resource
 
Zhen-Huan Hu
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Ana Nunes
Employment - Kite, a Gilead Company
 
David Dalton
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Bristol-Myers Squibb; Gilead Sciences
 
Ioana Kloos
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Daniel Lee
Employment - Kite, a Gilead Company
 
Hairong Xu
Employment - Kite, a Gilead Company
 
Marcelo C. Pasquini
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Medigene; Pfizer
Research Funding - Bristol-Myers Squibb; Kite, a Gilead Company; Novartis
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb